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INTRODUCTION 
Voice is an important aspect of human life, because it conveys the 
mood and feelings at any particular time. The laryngeal dysfunction 
produces symptoms which can vary from mild hoarseness to life 
threatening stridor. Benign laryngeal lesions are significant because of the 
importance of spoken or sung communication and the voice’s 
contribution to identity. Laryngeal lesions can create lot of mental and 
emotional tension in the patient and their family, more so in the case of 
professional voice users. Early and accurate diagnosis of the lesions can 
lead to effective management and good recovery. 
The development of endoscopy and micro laryngeal surgery 
provided ground breaking development in the field of laryngology. 
Further advancements are made in the recent years including the 
introduction of videostroboscopy and high speed and high definition 
photography. Videostroboscopy provides a multidimensional approach 
which immensely improves the accuracy of diagnosis and planning the 
management of benign lesions of the larynx. 
The field of laryngology took big leaps with the introduction of 
Lasers in 1960s for treating variety of laryngeal pathologies, both benign 
and malignant. The better understanding of microarchitecture of vocal 
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cords paved way for the use of Carbon dioxide laser in laryngeal lesions. 
The advent of Microspot Carbon dioxide laser (250microns) is an 
appropriate tool for excision of superficial lesions of vocal cords which 
were initially treated only by micro dissection.  
The constant search for minimally invasive micro laryngeal 
surgery with maximum intact function saw the introduction of 
radiofrequency assisted plasma ablation as a tool in benign lesions of the 
vocal cords. This technique has also got an added advantage of 
significantly faster recovery. The Radiofrequency assisted plasma 
ablation or Coblation is widely used in ENT surgeries like obstructive 
sleep apnea syndrome, tonsillectomy, turbinate reduction, etc. 
Our study intends to find out the difference in intra operative & 
post-operative outcome of Benign lesions of larynx, treated by 
Radiofrequency assisted plasma ablation and Carbon dioxide Laser, the 
potential advantages and disadvantages of each procedure, and any 
difference in duration of surgery. The steep learning curve for both of 
these procedures poses a significant challenge to the surgeon and 
drastically affects the outcome. In the hands of an experienced surgeon, 
the results of both procedures are fairly excellent with reduced surgical 
times and almost no complications. 
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AIM OF THE STUDY 
 
• To compare the treatment outcome in Benign lesions of larynx 
using  Radiofrequency assisted plasma ablation and Carbon 
dioxide laser 
• To find out whether there are significant or potential adverse 
effects of either procedure 
• To determine whether any of these procedures is preferred 
treatment of choice in specific conditions 
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REVIEW OF LITERATURE 
The medical literature was searched to identify studies and reviews 
relevant to benign lesions of larynx, their diagnosis, and management 
relevant to usage of radiofrequency assisted plasma ablation and Carbon 
dioxide laser. The list of studies included in this review are as follows: 
Aniket et al49 studied the incidence of various types of benign 
lesions of larynx and their modes of clinical presentation, etiological 
factors and correlate the clinical and histopathological diagnosis. They 
found out the male preponderance of the lesions, with vocal cord polyps 
and nodules constituting the majority of the cases. Voice abuse was found 
to be the most common precipitating factor and hoarseness is the most 
common presenting symptom. 
Similar study by Om Prakash et al53 also reiterated the above 
facts. They also added that non-neoplastic lesions are more common, and 
the peak incidence is at the 4 – 5th decades. 
Printza A52 et al studied the diagnostic value of Videostroboscopy 
in benign lesions of larynx and stressed the benefits of diagnosing small 
lesions of the vocal cords which were otherwise normal during 
unremarkable endoscopy, which is more important especially for 
professional voice users. 
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Mami Kaneko et al50 studied about the optimal period of voice 
rest after surgery for effective recovery. They suggested that absolute 
voice rest for a period of at least 2 weeks is essential for recovery. 
Sharon S. Tang et al51 studied the timing of voice therapy after 
surgery, they found out greater gains in vocal function and quality if the 
patients are started on voice therapy preoperatively and then continued 
postoperatively. 
Wang ZY et al55 analysed the outcome of benign lesions of larynx 
treated by radiofrequency ablation and found out that the technique is 
minimally invasive causing minimal trauma, less bleeding, high safety 
and causes very few complications. They also discuss about the wide 
applications of radiofrequency ablation in ENT. 
Anant Chouhan et al56 also did a study on Microscopic surgery 
with coblation for benign laryngeal lesion – recurrent respiratory 
papillomatosis. They found similar advantages like less bleeding, short 
procedure duration, fewer complications. 
The National Institute for Health and Clinical excellence and 
British Association of Otolaryngologists47 conducted a review of the 
safety and efficacy of radiofrequency ablation in recurrent respiratory 
papillomatosis. They found out reduced number of frequency of 
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procedures needed to maintain airway, but they were uncertain of the 
advantage over other gold standard methods like laser and cold steel 
excision.  
The evolution of lasers in laryngology was studied by Asil Tahir54, 
in which he discusses about the principles of laser surgery, the application 
of Carbon dioxide laser in larynx, other photoangiolytic lasers that can be 
used. He observed that promising results can be obtained by the use of 
laser in laryngeal lesions by way of improved hemostasis and effective 
tangential dissection. 
Hardik Shah et al48, compared the efficacy of laser with 
conventional techniques in treatment of benign vocal cord lesions. They 
found out that postoperative pain and intraoperative bleeding was less in 
patients treated with laser. But surgical technique for laser requires 
expertise and more training. 
THE LARYNX 
The human larynx is a complex organ which participates in the 
diverse roles of airway protection, respiration, and phonation. Based on 
Negus’s observations5 the order of priority of these roles is:  
(1) protection of the lower airway,  
(2) respiration, 
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(3) phonation.  
To perform these roles, the internal and external structures of the 
larynx interact under precise neural control, producing the most complex  
laryngeal functions. 
EMBRYOLOGY: 
 The larynx, trachea and lungs develop during the fourth week of 
embryologic development. 
The laryngotracheal or respiratory diverticulum begins as a 
thickening in the ventral wall of the foregut lumen immediately caudal to 
the fourth branchial arch. The lining of this diverticulum is derived from 
the endoderm of the primitive foregut. As the diverticulum elongates, it is 
invested by the splanchnic mesenchyme which gives rise to cartilaginous 
and muscular structures. The caudal end begins to dilate at the end of the 
fourth week to give rise to the bronchopulmonary buds, giving rise to the 
primordial lungs. Esophagus forms as a result of continued ventrocaudal 
elongation of the diverticulum as an outgrowth of the caudal aspect of the 
foregut. 
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Development of Larynx 
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EMBRYOLOGICAL DERIVATIVES 
STRUCTURE SOURCE 
Laryngeal mucosa Endoderm of cephalic part of foregut 
Laryngeal cartilages Mesenchyme 
Epiglottis Hypobranchial eminence 
Upper part of thyroid cartilage 4th branchial arch 
lower part of thyroid, cricoid, 
corniculate and cuneiform 
cartilages 
6th branchial arch 
 The epithelial lining of larynx is derived from the endoderm. 
Laryngeal cartilages are derived from the mesenchymal elements of 4th 
and 6th arches. Epiglottis derived from the hypobranchial eminence 
(which is a proliferation of mesenchyme in the ventral ends of 3rd and 
4th arches).  
 The primitive pharyngeal floor, which is the site of origin of the 
larynx, becomes the glottis. The segment of foregut which separates the 
primitive pharyngeal floor formed by the 4th branchial pouch becomes the 
supraglottic portion. Cephalic portion of the respiratory diverticulum 
forms the subglottic portion. 
 At birth, the larynx is situated in a much higher position at the C2 
or C3 level, whereas in adults it is in the level of C3 – C6. During first 
several years of life, larynx will develop at an accelerated rate, epiglottis 
 
 
10 
 
will achieve its mature shape. During growth and maturation, the descent 
of hyoid bone and larynx occurs, a phenomenon which is unique to 
humans, necessary for the larynx to perform its complex functions. 
LARYNGEAL CARTILAGES 
THRYOID CARTILAGE 
 Shield shaped cartilage, protects the inner anatomy of larynx. 
Consists of two wings – alae or laminae, which is open posteriorly and 
fused in midline – in males making an angle of 90 degrees, thereby 
forming a laryngeal prominence called Adam’s apple, whereas in females 
the prominence is absent due to the more obtuse fusing angle of 120 
degrees. Superiorly the fusion is deficient which forms the thyroid notch. 
Posterior border each lamina elongated superiorly and inferiorly 
thereby forming the superior and inferior horn or cornu. The Inferior 
cornu articulates with a facet on the cricoid cartilage to form the 
cricothyroid joint. The superior cornu attaches to the greater cornu of the 
hyoid bone via lateral thyrohyoid ligament. This ligament may contain 
small triteceal cartilages. 
At the attachment of the superior cornu to the ala of thyroid 
cartilage, a protuberance called superior tubercle is found. This superior 
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tubercle is of clinical significance as it marks the point 1cm below which 
the neurovascular bundle – the superior laryngeal artery and the nerve, 
pierce the thyrohyoid membrane. 
The sternothyroid and thyrohyoid muscles attach to the thyroid 
laminae at the oblique line on the anterior surface. The posterior edge of 
each thyroid laminae receives the attachment of the inferior pharyngeal 
constrictor muscle. 
The level of vocal cords lies closer to the lower border of the 
thyroid lamina when compared to the upper border – it is not at the 
midpoint, which is very important for the correct placement of window 
during thyroplasty to avoid medialisation of ventricular bands. 
CRICOID CARTILAGE 
 This is the only cartilage in the entire laryngeal framework to 
completely encircle the airway. It is signet ring shaped, comprises of deep 
broad quadrilateral lamina posteriorly 20-30mm in height, and a narrow 
arch 3-4mm in height anteriorly. Near the junction of the arch and lamina, 
a facet is present onto which the inferior cornu of the thyroid cartilage 
articulates. The lamina has sloping upper margins, containing articular 
facets for the arytenoid cartilages. A vertical ridge is present in the 
midline of the posterior surface of the lamina which gives attachment to 
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the longitudinal muscle of esophagus, and produces a shallow concavity 
on each side which gives origin to the posterior cricoarytenoid muscle. 
ARYTENOID CARTILAGES 
 These are paired, and placed close to each other on the upper and 
lateral borders of the cricoid lamina. Each arytenoid is a irregularly 
shaped three-sided pyramid with anteromedial projection called vocal 
process, which serves as attachment site for vocal cord and a lateral 
projection called muscular process, to which posterior and lateral 
cricoarytenoid muscles are attached. 
 Anterolateral surface, which is between the two processes, is 
divided into two fossae. Upper triangular fossa gives attachment to the 
vestibular ligament, and the lower fossa to the vocalis and lateral 
cricoarytenoid muscles. 
 Apex, which is flattened, articulates with the corniculate cartilage. 
The medial surface is covered by mucous membrane which forms the 
lateral boundary of the intercartilaginous portion of the rima glottidis. 
Posterior surface is entirely covered by the transverse arytenoid muscle. 
The base provides a smooth articulating surface for articulating with the 
cricoid. The posterior cricoarytenoid ligament which is firm, prevents 
forward movement of the arytenoid. 
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ACCESSORY CARTILAGES – CORNICULATE AND 
CUNEIFORM 
 The corniculate cartilages are two small, conical, nodules made of 
elastic cartilage which articulate forming a synovial joint or sometimes 
fuse with the apices of the arytenoid cartilages. 
 The cuneiform cartilages are also small, and made of elastic 
cartilage, placed in each margin of the aryepiglottic fold. 
EPIGLOTTIS 
 This is an oblong, leaf like sheet of elastic cartilage, which is 
attached, at its inferior end to the inner surface of the thyroid laminae, 
just above anterior commissure, by the thyroepiglottic ligament. this 
inferior end is called petiole. Upper broad part is directed upwards and 
backwards and the superior margin is free. 
 The sides of the epiglottis is attached to the arytenoid cartilages by 
the aryepiglottic folds, the free edge of which, together with free edge of 
epiglottis, form the boundary of the inlet of the larynx. The posterior 
surface is concave with a small central projection, the tubercle, in the 
lower part. On the anterior surface, the mucous membrane is reflected on 
to the posterior part of the tongue and the lateral pharyngeal wall forming 
the depression called vallecula. 
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 The hyoepiglottic ligament connects lower part of epiglottis to the 
hyoid bone. The space between the epiglottis and thyrohyoid membrane 
which is filled with fatty tissue and lymphatics, termed the Preepiglottic 
space of Boyer. 
 In infants and newborn, the epiglottis is omega shaped, which is 
long, deeply grooved, floppy. This aids in protection of nasotracheal 
airway during suckling. 
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Cartilages of Larynx 
 
 
 
Cartilages of Larynx 
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LARYNGEAL JOINTS 
CRICOTHYROID JOINT 
 It is a synovial joint, formed by the articulation of inferior cornu of 
thyroid cartilage and the facets on the cricoid lamina. The joint permits 
anteroposterior sliding and rotation of inferior thyroid cornu upon the 
cricoid. The subluxation of this joint result in exaggerated decrease in 
anterior cricothyroid angle (thereby aiding medialisation procedures 
which provide vocal cord tightening). 
CRICOARYTENOID JOINT 
 Also a synovial joint, its action changes the distance between the 
vocal process of the both arytenoids and also between each vocal process 
to the anterior commissure. The joint permits sliding, rocking and 
twisting motion. The combined action of intrinsic laryngeal muscles on 
the arytenoids causes alteration in the position and shape of the vocal 
cords. 
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LARYNGEAL MUSCULATURE 
INTRINSIC LARYNGEAL MUSCLES 
 These primarily are responsible for altering the length, shape, 
tension and spatial position of vocal cords. There are three major 
adductors, one abductor and one tensor muscle. 
ADDUCTORS 
LATERAL CRICOARYTENOID MUSCLE 
 Paired, attached to muscular process medially to the superior 
border of cricoid laterally. Contraction causes adduction and lengthening 
of vocal cords. 
THYROARYTENOID MUCSLE 
 Consists of two parts – internus and externus.  
 External part attaches anteriorly at anterior commissure, 
posterolaterally on the lateral surface of arytenoid. Contraction causes 
both vocal process to be brought closer, thereby vocal cords shortened 
and adducted. 
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Muscles of Larynx 
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Also called Vocalis, the internal part arises from anterior 
commissure, inserts to vocal process of arytenoid. Contraction causes 
vocal cords to be shortened and thickened. 
INTERARYTENOID MUSCLE 
 Non paired, consists of both transverse and oblique fibres. 
Contraction causes arytenoid adduction, causing closure of posterior 
glottis and narrowing of laryngeal inlet. 
ABDUCTOR 
POSTERIOR CRICOARYTENOID MUSCLE4 
 Arises from posterior cricoid lamina, runs diagonally, insert to 
muscular process of arytenoid. Contraction causes vocal fold abduction. 
This is the only abductor and principal controller of the glottis airway. 
Consists of two muscle bellies – horizontal belly, the medial portion of 
PCA, courses obliquely and attaches to medial aspect of muscular 
process, whereas vertical belly, the lateral portion of PCA, courses more 
vertically to attach to lateral aspect of muscular process. 
 Horizontal belly cause true vocal cord abduction, while Vertical 
belly plays a major role in changing vocal cord length and tension. 
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Posterior Cricoarytenoid Muscle 
 
TENSOR 
CRICOTHYROID MUSCLE 
 This muscle is located on the external surface of laryngeal 
cartilages. 
This also contains two bellies. The pars recta, more vertical belly, arise 
from superior rim of cricoid and inserts to inferior rim of thyroid 
cartilage. The pars obliqua, runs more obliquely. Contraction causes 
cricothyroid space narrowing anteriorly, resulting in lengthening, 
tightening and thinning of vocal cords, thereby increasing frequency. 
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EXTRINSIC LARYNGEAL MUSCLES 
 Infrahyoid strap muscles (sternothyroid, sternohyoid and 
thyrohyoid), mylohyoid, digastric, geniohyoid and stylopharyngeus – all 
these muscles act in conjunction to provide stability to larynx. 
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FIBROELASTIC TISSUES OF THE LARYNX 
 
QUADRANGULAR MEMBRANE 
 Attaches anteriorly to the lateral margins of the epiglottis, curves 
posteriorly to attach to arytenoid and corniculate cartilages. This structure 
and the overlying mucosa contribute the aryepiglottic folds. Each fold 
forms part of medial wall of each pyriform fossa. The inferior edge 
contributes the vestibular ligament.  
CONUS ELASTICUS 
 This is thicker, also called cricovocal ligament or cricothyroid 
ligament, attaches below to upper border of cricoid. The free upper 
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border constitutes the true vocal cord. Anteriorly the membrane is 
thickened in midline, called cricothyroid ligament. 
INTERIOR OF THE LARYNX2 
 The cavity of larynx extends from laryngeal inlet to the lower 
border of cricoid, divided by the vocal cords and the vestibular folds into 
three compartments. 
 Superior vestibule – above vestibular folds, the ventricle lies 
between vestibular folds and the vocal folds, subglottic space extends 
from the vocal folds to the lower border of the cricoid cartilage. 
 Pre-epiglottic space of Boyer, is a wedge shaped space in front of 
epiglottis, bound anteriorly by thyrohyoid ligament and hyoid. This space 
continues laterally on both sides with Paraglottic space of Tucker10, that 
is bound by thyroid lamina laterally, conus elasticus and quadrangular 
membrane medially and pyriform fossa mucosa posteriorly. 
GLOTTIS 
 The rima glottidis or glottis is the fissure between both vocal cords 
anteriorly and between vocal processes and base of arytenoids 
posteriorly. Average length of glottis varies between 23mm in men and 
16-17mm in women. 
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SUBGLOTTIS 
 This portion extends from the level of the vocal cords to the lower 
border of the cricoid cartilage.  
MICROANATOMY OF THE VOCAL CORDS1 
 Vocal cords are two fold like structures which extend from angle of 
thyroid cartilage to the vocal process of the arytenoid cartilages. Each 
cord is a multi-layered structure. This complex microanatomy allows the 
loose and pliable superficial mucosal layers to vibrate freely over the 
stiffer under layers. 
 The most superficial layer is the stratified squamous epithelium. 
Deep to this layer is the lamina propria which is subdivided into three 
layers – superficial, intermediate and deep, with increasing rigidity. The 
superficial lamina propria is composed of extracellular matrix, water and 
loose collagen and elastin, in a gelatinous matrix. The intermediate and 
deep lamina propria mainly contains collagen and elastin. These two 
layers form the vocal ligament. The potential space between superficial 
and intermediate lamina propria is called Reinke’s space. 
 
 
25 
 
 The anterior two thirds of the endoscopically visualised true vocal 
cords is the phonatory, or the membranous portion, whereas the posterior 
one third is the aphonatory (respiratory), or cartilaginous portion. 
 
Ultrastructure of  the Vocal Cord 
The layered structure is not uniform in along the length of the vocal cord. 
At the anterior end, a mass of collagenous fibres appear connected to the 
inner perichondrium of thyroid cartilage. Posterior to this mass, there is 
another mass of elastic fibres, which is continuous with intermediate 
lamina propria, called Anterior Macula Flava. Similarly at the posterior 
end of the membranous part of the vocal cord also a mass of elastic 
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fibres, called Posterior Macula Flava, is present. These structures serve as 
cushions to protect the vocal cords from mechanical damage during 
phonation. 
 Thus from a mechanical point of view, the layers can be 
reclassified as 
• Cover – epithelium and superficial lamina propria 
• Transition – intermediate and deep lamina propria 
• Body – vocalis muscle 
FIVE TISSUE LAYERS BODY COVER MODEL3 
EPITHELIUM 
MUCOSA COVER 
LAMINA 
PROPRIA 
SUPERFICIAL 
INTERMEDIATE VOCAL 
LIGAMENT 
TRANSITION 
DEEP 
THYROARYTENOID MUSCLE MUSCLE BODY 
VASCULATURE OF THE LARYNX2,6 
 The arterial supply is by the superior and inferior laryngeal arteries. 
Superior laryngeal artery is a branch of superior thyroid artery, which in 
turn arises from the external carotid artery, enters the thyrohyoid 
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membrane 1 cm anterior and superior to the superior tubercle. Inferior 
laryngeal artery is a branch of inferior thyroid artery, which enters the 
larynx between the fibres of inferior constrictor muscle and anastomoses 
with branches of the superior laryngeal artery. 
 The venous supply mirrors the arterial supply. 
LYMPHATIC DRAINAGE 
 Part of larynx above vocal cords drained by vessels accompanying 
superior laryngeal vein, empty into upper deep cervical lymph nodes, 
whereas the zone below vocal cords drain along with inferior laryngeal 
vein, into the prelaryngeal and pretracheal nodes, then to the lower deep 
cervical nodes. 
 The vocal cords is devoid of any lymphatics and acts as a 
watershed between upper and lower zones. 
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Blood Supply of Larynx 
NERVE SUPPLY 
 The superior laryngeal nerve, branch of vagus, supplies sensation 
to the glottis, supraglottis (internal branch) and motor supply to 
cricothyroid (external branch). 
 The recurrent laryngeal nerve, also a branch of vagus, enters larynx 
posteriorly adjacent to the cricothyroid joint. It innervates ipsilateral 
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posterior cricoarytenoid, interarytenoid, lateral cricoarytenoid, terminates 
in thyroarytenoid. Thus the recurrent laryngeal nerve supplies all the 
intrinsic muscles of the larynx except cricothyroid muscle. It also 
supplies glottic and subglottic mucosa. 
PHYSIOLOGY OF LARYNX7 
 The most primitive function is protection of lower airway. In 
humans, the larynx has evolved into a very complex and highly 
specialized organ not only for airway protection and control of 
respiration, but also for sound and phonation. The laryngeal reflexes are 
also important in airway protection against external stimuli and foreign 
bodies, they are – laryngospasm, the strongest laryngeal reflex, others are 
evolved reflexes like coughing, apnea, bradycardia, hypotension, etc. 
PHONATION 
 Phonation is one of the most complex and highly advanced of the 
laryngeal functions. It is the ability of the larynx to couple phonation with 
articulation and resonance which allows for production of speech. The 
vocal cords, as observed by frontal tomography and videostroboscopy, 
vibrate at 100 – 300 Hz during normal conversation, and more than 1000 
Hz during singing. The movement of the vocal cords, whether during 
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quiet respiration or in phonation, is a complex activity controlled by the 
combined activity of all the laryngeal muscles. 
 The thyroarytenoid and the lateral cricoarytenoid exhibit a burst 
like activity at the onset of phonation, then fade during sustained 
phonation. The interarytenoid muscle has an increased latency of 
contraction, which allows for sustained contraction during prolonged 
phonation. The cricothyroid increases the pitch and volume, whereas the 
posterior cricoarytenoid shows greatest activity during deep inhalation 
and sniffing action. 
 Phonation requires complex and precise communication between 
the central nervous system and the peripheral phonatory organs. Other 
factors like lung capacity, compliance of the chest wall, anatomy of the 
nasal, pharyngeal and oral regions, mental status, etc. also play a role. 
 The sequence of sound production starts at the activation of 
Broca’s area, transmitted to motor cortex (precentral gyrus), which in turn 
stimulates motor nuclei in brainstem and spinal cord. The impulse is then 
processed by the respiratory, laryngeal and the articulatory musculature 
which in turn produces movement of the phonatory organs that result in 
production of sounds known as voice. Additional refinement is done by 
 
 
31 
 
the feedback mechanism, extrapyramidal and autonomous nervous 
system. 
 The initiation of voice requires vocal cords to rapidly abduct to 
allow the intake of air. This is called Prephonatory inspiratory phase by 
Wyke9. The production of voice then involves 
• A power source – coordinated functions of diaphragm, abdominal 
and chest muscles, lungs and chest wall. The pulmonary reserve is filled 
as a consequence, followed by the movement of air towards subglottis, 
thereby increasing subglottic pressure which in turn causes the air to flow 
between adducted vocal cords leading to their vibration. 
• Oscillator – four main parts of larynx involved are skeleton, 
mucosa, intrinsic and extrinsic muscles. 
• Resonance chamber – pharynx, oral cavity, nose, paranasal 
sinuses, and also chest to some extent. This helps to amplify the produced 
sound. 
THE GLOTTAL CYCLE 
 Each vibratory cycle of the vocal cords has three phases 
• Adduction 
• Aerodynamic separation 
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• Recoil 
As the subglottic pressure increases, the resistance of the adducted vocal 
cords is overcome; the vocal cords then peel apart from the inferior 
border. Later superior margin is separated thereby releasing a puff of air. 
This leads to drop in the subglottic pressure, the myoelastic tension of 
vocal cords exceeds which causes them to approximate. This is assisted 
by aerodynamic forces (Bernoulli’s principle). Again subglottic pressure 
begins to increase till the vocal cords are pushed apart. This completes 
one Glottal cycle. It is the number of cycles per second that determines 
the frequency or pitch of the sound. This model of voice production is 
called myoelastic – aerodynamic theory. 
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GLOTTAL CYCLE 
 
CLINICAL ASSESSMENT OF VOICE DISORDERS 
NORMAL VOICE 
 Usually described as 
• Audible, clear and stable 
• Appropriate for age and sex 
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• Able to fulfill linguistic functions 
• Not easily fatigable 
• No associated discomfort or pain 
DISORDERED VOICE 
 Usually multifactorial, these are the main processes that contribute 
to disordered voice. 
• Inadequate breath support (energy) – severe structural and 
inflammatory pathology in lower airway or chest wall, weakness of 
respiratory muscles, primary abnormal breathing patterns, etc. 
• Dysfunction of vibratory apparatus – muscle tension dysphonia, 
neuromuscular disorders, structural and inflammatory changes in vocal 
cords, etc. 
• Ineffectiveness of vocal tract resonating chamber – structural 
abnormality, neuromuscular deficits, inflammation, muscle tension 
imbalance of any part will affect the resonance characteristics and hence 
the voice quality. 
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ASSESSMENT OF VOICE21 
CLINICAL ASSESSMENT 
 All the patients with voice disorder should be treated by a team of 
Otolaryngologist and Speech pathologist. Availability of 
videostroboscopy is a key element in aiding with the early diagnosis. 
HISTORY 
 Detailed history taking is of utmost importance which includes 
 Nature and duration of the problem 
 Accentuating and relieving factors 
 Lifestyle issues 
 Other comorbid conditions contributing to the symptoms 
 Patient’s requirements and expectations for outcome 
 Patient’s complaints – changes in voice quality, pitch, 
inability to raise the voice, reduced stamina, reduced ability 
to communicate, other throat symptoms 
 Emotional and psychological factors 
Self assessment questionnaires like the Voice Handicap Index, 
Voice related quality of life, Voice symptom scale, etc. have been 
 
 
36 
 
developed on the basis of symptoms of patients attending outpatient 
department with voice problems. 
ENDOSCOPIC EXAMINATION 
 After arriving at a preliminary diagnosis based on the history, the 
examination of larynx is done to confirm the same. A rigid endoscope (70 
degrees), high definition camera with a stroboscopic light source gives 
the best quality of imaging of the mucosal wave. Flexible nasendoscope 
allows examination of entire vocal tract. 
 Patient is asked to do phonatory (sustained phonation of vowel 
sounds) and non phonatory (coughing, sniffing) tasks, each anatomical 
subsite is checked for the offending pathology. 
VIDEOSTROBOSCOPY12, 14-19 
 It provides a slow motion perception of the mucosal waveform of 
the vibrating vocal cords. The following parameters are assessed: 
• Fundamental speech frequency 
• Periodicity – regularity of successive mucosal waves 
• Symmetry 
• Glottic closure – complete or incomplete 
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• Mucosal wave – correlate of the pliable cover displacement relative 
to body of the vocal cord. Focal abnormalities can be detected. 
 Based on the diagnosis arrived, appropriate protocol for 
management is planned according to the nature of the disease and 
patient’s requirements. 
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Glottal cycle  - Videostroboscopy 
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PREOPERATIVE VOICE THERAPY20 
 It is mainly aimed at coordinating voice production and breathing, 
a process termed as Pneumophonic coordination. Voice therapy primarily 
treats the cause and not the consequence. A short preoperative therapy is 
provided to all patients planned for surgery as it prepares the patient for 
the long term postoperative period of voice rehabilitation. 
BENIGN LESIONS OF THE LARYNX25, 26 
 The benign lesions include vocal nodules, vocal polyps, Reinke’s 
edema, laryngeal cysts, laryngeal webs, laryngoceles, granulomas, 
recurrent respiratory papillomatosis, sulcus vocalis, vascular lesions, 
amyloidosis, chronic granulomatous diseases, etc. Most patients present 
with disordered voice or dysphonia. All the patients who were diagnosed 
with benign laryngeal pathology should undergo trial voice therapy 
before definitive surgery is planned. Other contributing factors must be 
addressed to prevent any recurrence after surgery. Compliance to 
postoperative voice rehabilitation is also very important for avoiding 
recurrence. 
VOCAL CORD NODULES 
 Also called “Singer’s nodules”. These are benign, localised, 
usually bilateral, mucosal swellings of the medial surface of membranous 
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portion of the vocal cords. Vocal nodules are typically located at the 
junction of anterior and middle thirds of the vocal cords. This results 
from voice misuse or abuse in prepubertal age and non professional 
singers with poor singing technique, thereby causing phonotrauma. 
 Treatment involves voice therapy and education, which plays an 
integral role. About 90% cases will become asymptomatic with voice 
therapy alone. Surgery may be considered for patients with persistent 
symptoms despite complying with voice therapy. 
VOCAL CORD POLYPS27 
 These are generally unilateral, also resulting from phonotrauma. It 
is an inflammatory pseudotumour of the vocal cord, which is frequently 
seen in middle aged men who are smokers. Polyps are usually situated at 
the junction of anterior and middle thirds of vocal cords, may be pedicled 
or sessile, with a variable size. Edematous polyps are usually pink in 
colour whereas Hemorrhagic polyps are bright red in colour. Sometimes 
there may be associated sulcus glottidis which must be treated alongside. 
 Treatment is always surgical, with preoperative and postoperative 
voice therapy. 
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REINKE’S EDEMA 
 Also called Diffuse polypoidal corditis, usually seen in persons 
with history of excessive smoking and voice abuse. A clear predilection 
among middle aged women is noted. It results from fluid accumulation in 
the Reinke’s space. Patients usually present with dysphonia, sometimes, 
if the lesion is causing mass effect, may present with dyspnea and stridor. 
 Treatment is multimodal, aimed at smoking cessation and avoiding 
voice abuse and in addition, speech therapy. Surgery is done in severe 
cases, using cold techniques or CO2 laser. 
LARYNGEAL CYSTS 
 Mucous retention cysts: These are formed due to cicatrical 
obstruction of mucous gland ducts, usually unilateral, appear translucent 
and lined by cuboidal or columnated epithelium. 
 Epidermoid cysts: These contain accumulated keratin in the 
subepithelial layer. Also called intracordal cysts, these are usually the 
result of repeated trauma due to vocal abuse. 
 Treatment involves medical therapy to reversing or eliminating 
precipitating factors like allergy, acid reflux, etc. If symptoms are 
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persistent, then surgery is planned after few sessions of voice therapy 
followed by long term voice rehabilitation. 
LARYNGOCELES 
 It is an abnormal, air filled dilatation or herniation of the ventricle 
of Morgagni. When filled with air, they communicate with the laryngeal 
lumen. Sometimes the neck of sac may get obstructed leading to 
mucocele, which later gets infected and becomes laryngopyocele.  
 Classification depends on their location – internal, external or 
combined. Internal Laryngoceles are confined within the thyroid 
cartilage. External Laryngoceles lie outside the cartilaginous framework. 
Combined Laryngoceles span both the inside and outside of the thyroid 
cartilage.  
 Surgery is the only definitive treatment.  
GRANULOMAS 
 These are usually unilateral, located on the posterior third of the 
vocal cords, i.e. vocal process of the arytenoids. Common causative 
factors are gastroesophageal reflux, traumatic or prolonged intubation, 
voice misuse. 
Treatment is surgical, after addressing the causative factors. 
 
 
43 
 
RECURRENT RESPIRATORY PAPILLOMATOSIS 
 It is a benign epithelial tumour, which presents as a warty, 
exophytic mass, which can occur in aerodigestive tract where there is 
increased airway turbulence. Primarily involves larynx, but aggressive 
lesions may also involve trachea, bronchi, pharynx or tonsils. The disease 
is caused by Human Papilloma Virus (types 6 & 11, with the latter having 
worst prognosis). Unique bimodal age distribution is noted – juvenile 
onset RRP and the adult onset RRP. The disease has a male 
preponderance of 4:1 ratio. Malignant transformation may occur in 1 – 
7% of cases. Surgery is the standard treatment of choice with adjuvant 
treatment with Cidofovir, Interferon, and effective control of Gastro 
esophageal reflux also being considered. 
SULCUS VOCALIS 
 A groove that is present along the vocal cord mucosa, though 
subtle, can cause voice dysfunction. Classified into three types: 
• Physiologic or pseudosulcus 
• Sulcus vergeture – deficient area upto superficial lamina propria 
• Sulcus vocalis – epithelial lined pocket extending to deeper layers 
Treatment is surgical if the symptoms are severe and no benefit is 
achieved by speech therapy. 
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Healthy Larynx 
 
Vocal Nodule  
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Vocal Polyp 
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Intracordal Cyst 
 
Laryngeal Papilloma 
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Reinke's Edema 
 
Sulcus vocalis 
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LASERS IN LARYNGOLOGY 
Albert Einstein first discussed about Stimulated Emission in 1917, 
and in 1958, Townes published theoretic calculations termed LASER. In 
1961, Neodymium doped was developed, followed by Nd-YAG and 
Argon in 1964. LASER was introduced in otolaryngology by Strong and 
Jako33 in 1972, it can be used for incision, excision and vaporization of 
tissue.  
LASER is an acronym for Light Amplification by the Stimulated 
Emission of Radiation. Light beam has 4 main properties – intensity, 
coherence, high collimation and monochromaticity. 
 Amplification – the electromagnetic emission released is amplified 
by an external power source to produce an intense beam, that excite 
atoms, which results in emission of photons from the atoms, thus creating 
a chain reaction. 
 Stimulated emission of radiation – spectrum of wavelengths 
ranging from 200nm (ultraviolet) to 10000nm (infrared). 
 The most common lasers used in surgery are: 
 500nm – Argon laser 
 532nm – Potassium-titanyl-phosphate (KTP) laser 
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 585nm – Dye laser 
 1060nm- Neodymium Yttrium Aluminium Garnet (NdYAG) 
laser 
 10600nm – Carbon dioxide (CO2) laser 
COMPONENTS OF SURGICAL LASER 
1. Active medium of laser 
2. Power source to pump energy 
3. Optical chamber 
LASER INTERACTION WITH TISSUE 
Mitashi et al in 1976 described the interaction of laser with human 
tissue. Four possible interaction may occur when a laser beam makes 
contact with the tissue: 
1. Reflection – beam neither absorbed nor does pass through 
2. Transmission – beam not absorbed but passes directly through 
3. Absorption – beam fully absorbed by the tissue 
4. Scatter / dispersion – beam partially absorbed, transmitted, and 
scattered by the tissue 
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CARBON DIOXIDE LASER 
The wavelength of  Carbon Dioxide Laser is 10600nm. This is  
best suited for absorption by water, which is an important characteristic, 
because absorption of this wavelength into soft tissue (90% water 
content) will concentrate the energy, thereby permitting little heat to 
dissipate into the surrounding tissues as described by Mitashi et al in 
1976. 
Mechanism of action: 
The CO2 laser light is transformed within the tissue into thermal 
energy, raising the temperature to 100 degree Celsius, vaporizes the 
tissue’s water content. This makes CO2 laser a precise cutting tool, ideal 
for excision of small lesions located on vocal cords. It also gives depth of 
penetration with minimal damage to surrounding tissues. It has got a good 
hemostatic capability (limited to capillaries 0.5mm diameter). 
 The endoscopic use of CO2 laser with a microspot technology36 
(250microns size) permits excellent precision and good hemostasis, 
which is not always the case with cold instruments. The development of 
microspot manipulator46 facilitated tissue excision with precise cutting 
and minimal damage to surrounding mucosa and underlying vocalis 
muscle. 
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 The CO2 laser has been used in various laryngeal lesions40, and is 
especially effective for: 
 Vocal cord polyps 
 Large sessile nodules 
 Vocal cord cysts 
 Laryngeal cysts 
 Vocal cord granulomas 
 Laser assisted myoneurectomy in Spasmodic dysphonia 
 Subtotal arytenoidectomy and Unilateral posterior cordectomy in 
Bilateral abductor palsy 
 Glottic webs 
 Reinke’s edema 
 Biopsy in Chronic laryngitis follow up 
 Recurrent respiratory papillomatosis 
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OTHER LASERS OF CLINICAL SIGNIFICANCE: 
NEODYMIUM YTTRIUM ALUMINIUM GARNET LASER 
 Wavelength of 1060nm, hence poorly absorbed by water, 
penetrates tissue deeply, especially well absorbed by pigmented and 
vascular tissue. It is mainly used in the tracheobronchial tree. The thermal 
effect goes beyond its immediate area of visible impact, so care must be 
taken to apply it in brief pulses of 1 second or less at a power setting 
below 50W. 
DIODE LASER 
 Sturdy and compact semiconductor laser, portable and requires 
minimal maintenance. The disadvantage is that the variability in 
penetration during cutting. 
HEMOANGIOLYTIC LASERS 
 532nm KTP laser and 585nm pulse dye laser both are best 
absorbed by oxyhemoglobin, therefore useful in vascular lesions such as 
papillomas and dysplasias. 
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RADIOFREQUENCY ASSISTED PLASMA ABLATION28: 
 Otherwise termed coblation, this is first discovered by Hira V. 
Thapliyal and Philip E. Eggers. This involves non thermal volumetric 
tissue removal through plasma dissociation. This technology uses the 
principle that when an electric current is passed through a conducting 
fluid (like cold saline), a charged layer known as the plasma is generated, 
which has the tendency to accelerate, gain energy, and break bonds 
between the cells ultimately resulting in volumetric reduction of the 
tissue.  
 Otolaryngological surgeries where coblation technology has been 
found to be useful include: 
1. Adenotonsillectomy 
2. Tongue base reduction 
3. Tongue channeling 
4. Uvulo palato pharyngoplasty 
5. Cordectomy 
6. Removal of benign lesions of larynx including papilloma29 
7. Kashima's procedure for bilateral abductor paralysis 
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8. Turbinate reduction 
9. Nasal polypectomy 
Components of coblation system: 
1. RF Generator 
2. Foot pedal controller 
3. Irrigation system 
4. Wand 
 Coblation 
Other electrosurgical 
devices 
Temperatures 40 – 700 C 400 – 6000C 
Thermal penetration Minimal Deep 
Effects on Target 
tissue 
Gentle removal / 
dissolution 
Rapid heating, 
charring, burning 
Effects on surrounding 
tissue 
Minimal dissolution 
Inadvertant charring / 
burning 
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Procise LW Wand 
With a default set up of 7 for ablation and 3 for coagulation, this 
wand has got the following advantages: 
 Efficient bipolar ablation and coagulation 
 Long and malleable – offers increased surgical field visualization, 
excellent adaptability to the individual’s anatomy, adequate access 
to anterior commissure 
 Integrated saline irrigation and suction – provides optimum saline 
delivery to active electrodes irrespective of the orientation 
All these factors collectively help in reduced surgical times and 
overall complications and more importantly improved precision even for 
anterior commissure lesions, which is of paramount importance in 
laryngeal surgeries. 
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Vocal Polyp 
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Procise LW Wand in action 
 
 
 
Immediate Post Operative period 
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MATERIALS AND METHODS 
TYPE OF STUDY: 
Prospective Randomized Double Blind Clinical Trial 
STUDY PERIOD: 
June 2015 to May 2017 
NUMBER OF CASES: 
30 
SOURCE OF DATA: 
Patients who were presenting to ENT Outpatient department, 
Government Coimbatore Medical College Hospital, Coimbatore, with 
voice complaints. 
INCLUSION CRITERIA: 
All patients who are 18 years or older (to exclude the possibility of 
inconsistencies in voice during puberty), diagnosed to have Vocal cord 
polyps, vocal cord nodules, mucous retention cysts, epidermoid cysts, 
Reinke’s edema, recurrent laryngeal papillomatosis, etc. 
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EXCLUSION CRITERIA: 
Persons diagnosed to have  
• malignant lesions 
• pregnant women 
• mentally impaired persons 
• persons with comorbid medical conditions who cannot tolerate 
general anesthesia 
• patients who show good response with voice therapy and 
medical management 
METHODOLOGY: 
Adult patients who were presenting to ENT OPD with voice 
complaints like hoarseness, breathy or rough voice, diplophonia, etc. are 
evaluated. Complete head and neck examination and Indirect 
laryngoscopy examination (with topical 10% lignocaine spray if required) 
was done. Patients suspected to have benign lesions of the larynx like 
vocal cord polyps, vocal cord nodules, Reinke’s edema, recurrent 
laryngeal papillomatosis, intracordal cysts, etc. are subjected to 
Videostroboscopy and diagnosis is confirmed. The patients are randomly 
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allocated for the proposed treatment modalities – Radiofrequency assisted 
plasma ablation and Carbon dioxide laser. 
Pretreatment voice assessment was made using Voice Handicap Index 
– 10 (subjective) and Maximum Phonation Time (MPT).  
VOICE HANDICAP INDEX – 10: 
It is a self reporting questionnaire23, 24 by the patient regarding the 
voice symptoms, a set of 10 questions, and the response was graded on a 
scale of 0 – 4. Based on the response by the patients, the scores are 
obtained. Generally scores greater than 11 is considered significant for 
voice pathology. 
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MAXIMUM PHONATION TIME (MPT): 
This is calculated by asking the patient to take a deep breath, then 
sustain a vowel sound like “ah” or “ee” for as long as possible in pitch 
and loudness in which the patient is comfortable on one exhalation. The 
time22 is recorded in seconds using a stopwatch. Two more of such 
attempts are made. The longest time recorded of the three is taken into 
account for calculation of MPT. The value is considerably reduced in 
cases with voice pathology. 
MAXIMUM PHONATION TIME 
SEX TIME (SECONDS) 
MEN 25 – 35 
WOMEN 15 - 25 
VIDEOSTROBOSCOPY: 
Preoperative Videostroboscopic findings19 were also recorded with 
respect to 4 parameters: 
• Glottal closure 
• Regularity 
• Mucosal wave 
• Symmetry 
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All the patients were subjected to preoperative voice therapy13 to prepare 
the patient for a prolonged postoperative voice rehabilitation. 
SURGERY: 
The patients who agreed to participate in the study, with duly 
signed consent forms, were randomly assigned to receive radiofrequency 
assisted ablation or laser excision.  
All the patients were operated under general anesthesia with 
endotracheal intubation with the finest possible tube diameter. Then 
Kleinsasser’s Suspension Laryngoscope was introduced with a rigid 
endoscope connected to a high definition camera and a monitor. 
For Radiofrequency assisted ablation: 
Procise LW Wand with integrated cable was used with a foot pedal 
controller, the base of the lesion in the vocal cord was traced as it is held 
with a forceps, and the base was then cut and ablated till the basal 
attachment was completely cut off. 
For Carbondioxide laser excision: 
Endotracheal intubation with a laser safe tube was done. Operating 
microscope with a focal length of 400 mm was used after introducing the 
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Suspension Laryngoscope. Carbondioxide microspot laser (250 microns) 
with superpulse mode was used, and adequate care was taken to dissect 
the lesion in the most superficial plane as possible, to avoid any trauma to 
the deep layers of the vocal cord. 
Specimens were sent to histopathology for accurate tissue 
diagnosis. All the patients were given a dose of 8mg Dexamethasone IV 
intraoperatively. Surgical duration is noted. Complications, if any, are 
noted. All the patients were advised strict voice rest for first 2 weeks 
following surgery. 
Postoperative follow up was done at 2 weeks and 8 weeks from the day of 
surgery. Videostroboscopic parameters and Voice assessment with Voice 
Handicap Index – 10 and Maximum Phonation Time are recorded. The 
outcome was compared and final analysis of results was done. 
Outcome: 
The cure was defined as the subjective feeling of improved voice 
quality and normal bilateral vocal cord mobility with constant periodicity 
and normal mucosal wave. The pre and postoperative MPT scores at 2 
weeks and 8 weeks, pre and post-operative VHI scores are also taken into 
consideration. 
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OBSERVATION AND ANALYSIS 
AGE –WISE DISTRIBUTION OF THE STUDY PARTICIPANTS 
Age-Group Frequency Percentage 
21-30 years 3 10.0 
31-40 years 5 16.7 
41-50 years 7 23.3 
51-60 years 10 33.3 
61-70 years 5 16.7 
Total 30 100.0 
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AGE 
 N Minimum Maximum Mean 
Std. 
Deviation 
AGE 30 26 65 48.17 11.859 
 
SEX-WISE DISTRIBUTION OF THE STUDY PARTICIPANTS 
Sex Frequency Percentage 
Males 23 76.7 
Females 7 23.3 
Total 30 100.0 
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Clinical Presentation Frequency Percentage 
HOARSENESS 15 50.0 
BREATHY VOICE 5 16.7 
ROUGH VOICE 9 30.0 
DIPLOPHONIA 1 3.3 
Total 30 100.0 
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Diagnosis Frequency Percentage 
VOCAL CORD POLYP 14 46.7 
VOCAL CORD NODULE 8 26.7 
RECURRENT LARYNGEAL 
PAPILLOMATOSIS 
2 6.7 
REINKE'S EDEMA 2 6.7 
VOCAL CORD CYST 2 6.6 
SULCUS VOCALIS 1 3.3 
VOCAL CORD GRANULOMA 1 3.3 
TOTAL 30 100.0 
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RISK FACTORS/ PRECIPITATING FACTORS 
Precipitating / Risk factors Frequency Percentage 
SMOKER 11 36.67 
VOICE ABUSE 10 33.33 
LARYNGOPHARYNGEAL 
REFLUX 
5 16.67 
OTHERS 1 3.3 
NIL 8 26.7 
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DESCRIPTIVE STATISTICS 
 N Minimum Maximum Mean 
Std. 
Deviation 
PRE TREATMENT 
VHI SCORE 
30 11 18 13.00 1.894 
 
VHI Score Frequency Percentage 
Normal 8 26.7 
Abnormal 22 73.3 
Total 30 100.0 
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DESCRIPTIVE STATISTICS 
 N Minimum Maximum Mean 
Std. 
Deviation 
PRE TREATMENT 
MPT SCORE 
30 12 26 18.47 3.159 
 
 
PRETREATMENT MPT 
Gender Duration Frequency Percentage Total 
Females Normal (15-25 s) 3 42.9  
7 Abnormal  
(less than 15 s) 
4 57.1 
 
Males 
Normal (25-35 s) 1 4.3 23 
Abnormal (less 
than 25 s) 
22 95.7 
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Treatment Groups Frequency Percentage 
Coblation Therapy 15 50 
Laser Therapy 15 50 
 
SURGICAL TIME (IN SECONDS) 
Treatment 
Method 
Minimum Maximum Mean SD 
Coblation 10 30 18.00 5.398 
LASER 18 30 24.20 4.296 
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COMPARISON BETWEEN TWO METHODS 
Treatment 
Method 
Mean 
In seconds 
SD 
Non-parametric Test 
(Mann Whitney U test) 
P value 
Coblation 18.00 5.398 
0.41 .002 
LASER 24.20 4.296 
 
The mean difference between the two methods is 6.2 seconds and it 
is obvious the duration for coblation therapy is less compared to LASER 
treatment and is found to be statistically significant by Mann Whitney U 
test 
COMPLICATIONS 
Treatment Groups Frequency Complications 
Coblation Therapy 15 NIL 
Laser Therapy 15 NIL 
 
In both treatment modalities there are no complications 
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RECOVERY TIME 
Treatment 
Method 
MPT Score Minimum Maximum Mean SD 
Coblation 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
12 26 17.87 3.833 
MPT SCORE 
AT 2 WEEKS 
14 28 20.47 3.944 
MPT SCORE 
AT 8 WEEKS 
14 28 22.20 4.459 
Laser 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
14 23 19.07 2.282 
MPT SCORE 
AT 2 WEEKS 
17 27 21.40 2.720 
MPT SCORE 
AT 8 WEEKS 
20 31 24.20 3.385 
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COMPARISON OF MPT SCORE WITHIN THE TREATMENT GROUPS 
Treatment 
Method 
MPT Score Mean SD 
Mann Whitney 
U Test 
P 
value 
Coblation 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
17.87 3.833 
84.5 <0.05 
MPT SCORE 
AT 2 WEEKS 
20.47 3.944 
Laser 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
19.07 2.282 
91.5 .381 
MPT SCORE 
AT 2 WEEKS 
21.40 2.720 
 
Treatment 
Method 
MPT Score Mean SD 
Mann Whitney  
U Test 
P 
value 
Coblation 
Therapy 
MPT SCORE 
AT 2 WEEKS 
20.47 3.944 
91.50 .381 
MPT SCORE 
AT 8 WEEKS 
22.20 4.459 
Laser 
Therapy 
MPT SCORE 
AT 2 WEEKS 
21.40 2.720 
87.00 .289 
MPT SCORE 
AT 8 WEEKS 
24.20 3.385 
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Treatment 
Method 
MPT Score MEAN SD 
Mann 
Whitney U 
Test 
P value 
Coblation 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
17.87 3.833 
82 <0.05 
MPT SCORE 
AT 8 WEEKS 
22.20 4.459 
Laser 
Therapy 
PRE 
TREATMENT 
MPT SCORE 
19.07 2.282 
56 <0.05 
MPT SCORE 
AT 8 WEEKS 
24.20 3.385 
 
COMPARISON OF MPT SCORES BETWEEN THE TWO GROUPS 
 TREATMENT N Mean 
Std. 
Deviation 
F value P value 
PRE 
TREATMENT 
MPT SCORE 
1 15 17.87 3.833 
4.183 .306 
2 15 19.07 2.282 
MPT SCORE 
AT 2 WEEKS 
1 15 20.47 3.944 
3.005 .457 
2 15 21.40 2.720 
MPT SCORE 
AT 8 WEEKS 
1 15 22.20 4.459 
1.990 .177 
2 15 24.20 3.385 
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VHI SCORE 
 Minimum Maximum Mean Std. Deviation 
PRE TREATMENT VHI 
SCORE 
11 18 13.00 1.89 
POST TREATMENT VHI 
SCORE 
5 13 8.03 1.93 
 
 
TREATMENT Minimum Maximum Mean 
Std. 
Deviation 
Coblati
on 
PRE TREATMENT 
VHI SCORE 
11 16 13.60 1.72 
POST TREATMENT 
VHI SCORE 
5 13 8.93 1.90 
LASER 
PRE TREATMENT 
VHI SCORE 
11 18 12.40 1.92 
POST TREATMENT 
VHI SCORE 
5 10 7.13 1.55 
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COMPARISON BETWEEN THE VHI SCORE 
Treatment 
Method 
VHI Score MEAN SD 
Mann Whitney 
U Test 
P value 
Coblation 
Therapy 
PRE 
TREATMENT 
VHI SCORE 
13.60 1.72 
11.06 <0.05 
POST 
TREATMENT 
VHI SCORE 
8.93 1.90 
Laser 
Therapy 
PRE 
TREATMENT 
VHI SCORE 
12.40 1.92 
18.4 <0.05 
POST 
TREATMENT 
VHI SCORE 
7.13 1.55 
 
GROUP STATISTICS VHI 
 TREATMENT N Mean 
Std. 
Deviation 
F 
value 
P 
value 
PRE 
TREATMENT 
VHI SCORE 
1 15 13.60 1.724 
.018 .082 
2 15 12.40 1.920 
POST 
TREATMENT 
VHI SCORE 
1 15 8.93 1.907 
.029 .008 
2 15 7.13 1.552 
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OUTCOME 
Gender Outcome Frequency Percentage 
Coblation Favorable 14 93.3 
Recurrence 1 6.7 
LASER Favorable 15 100.0 
Recurrence Nil - 
 
 
 
 
 
 
 
14
15
1
0
Coblation LASER
OUTCOME OF THE TREATMENT METHOD
Favourable Recurrence
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DISCUSSION 
This study was intended to compare the outcome in Benign lesions 
of Larynx treated using Radiofrequency assisted plasma ablation and 
Carbon dioxide Laser. The study also aimed to find out whether there are 
any significant complications in any of the procedure and whether one 
method is preferred over another in any circumstance. 
This study is a prospective randomized double blind clinical 
study. 
30 patients with voice complaints who were diagnosed with benign 
lesions of the larynx are selected and randomly allocated into two groups 
of 15 each. The two groups were identically evaluated and prepared for 
surgery. Pretreatment attributes, surgical and recovery times, post 
treatment improvement was evaluated and compared. 
Hoarseness was the most common presenting symptom, followed 
by roughness. Of the total 30 cases, 15 presented with hoarseness, 9 
presented with roughness, 5 presented with breathy voice, diplophonia 
was present in one patient. 
In men smoking was the main risk factor associated with the 
benign laryngeal lesions. Out of 23 men in the study group, 11 were 
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smokers, which is a significant proportion. In women voice abuse was the 
main precipitating factor causing the voice symptoms. Other important 
risk factor in both genders is uncontrolled laryngopharyngeal reflux. One 
patient had history of previous endotracheal intubation following which 
he developed Vocal cord granuloma. 
Pretreatment VHI-10 Score: 
22 of the 30 patients had abnormally high VHI scores, the 
remaining 8 patients had a borderline VHI scores, which further 
highlights the importance and clinical ease of using this tool as a reliable 
indicator of voice dysfunction. The mean VHI score is 13.00 with a 
standard deviation of 1.894. 
Pretreatment MPT score: 
95.7% of males and 57.1% of females in the study group had 
abnormal pretreatment MPT score. The mean MPT score of the study 
population was 18.47 with a standard deviation of 3.159. 
Surgical Times: 
The mean surgical time of Coblation surgery is 18.00 minutes, with 
a standard deviation of 5.398, whereas for Carbon dioxide Laser, the 
mean time is 24.20 with a standard deviation of 4.296. 
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The mean difference of 6.2 between the two methods shows that 
the surgical times with coblation method are significantly lower than that 
of  Carbondioxide laser (Mann Whitney U Test 0.41, p value <0.05). 
Recovery times: 
MEAN MPT 
SCORE 
PRETREATMENT 
2 WKS 
POSTOP 
8 WKS 
POSTOP 
COBLATION 17.87 20.47 22.2 
LASER 19.07 21.40 24.20 
 
The Mean MPT score in the coblation group showed statistically 
significant improvement after 2 weeks postoperatively, with further 
improvement after 5 weeks postoperatively. In Laser group, mean MPT 
score did not show significant improvement at 2 weeks, but eventually 
showed improvement at 8 weeks. 
One case of recurrence was a case of Laryngeal papilloma, which 
occurred at a site different from the previous surgery done at our hospital, 
and was successfully treated by second surgery, following which the 
patient is symptom free. 
 
 
 
85 
 
Based on the above observation, it can be inferred that though both 
the methods are similar in terms of outcome, Laser surgery has 
significantly longer surgical times, and recovery also takes slightly longer 
when compared to Coblation surgery. This is attributable to the fact that 
Coblation carries less risk of injuring surrounding tissue, and that it 
operates at a much lesser temperature (40 – 70 degrees Centigrade) than 
that of Laser, which, on the other hand operates at 300 degrees 
Centigrade, which may cause heat damages in the lamina propria and 
deep tissues of the vocal cords.  
LIMITATIONS OF THE STUDY: 
Because of the lack of availability of acoustic and aerodynamic 
analyses in our current set up, we mainly used videostroboscopic 
assessments and patient perceived tools like Voice Handicap Inventory 
10, Maximum phonation time, etc.  
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CONCLUSION 
This study suggests that Radiofrequency assisted plasma ablation 
and Carbon dioxide Laser both are excellent treatment modalities for the 
surgical management of Benign Lesions of the Larynx in the hands of an 
experienced surgeon. 
There were no detectable differences in the outcome between the 
two methods and there were no complications in any of these methods.  
The delay in recovery times, as evidenced by lower MPT scores at 
2 weeks for Laser can be attributed to the fact that it operates at a higher 
temperature thereby causing more thermal damage to surrounding tissues. 
But at the end of 8 weeks, the scores are similar to both modalities. 
Coblation, though an excellent tool with much lower complications 
than any other electrosurgical modalities, carries a huge disadvantage of 
incurring cost of wands. This is not the case in Laser, as the setup 
involves one-time investment with no incurring cost thereafter. 
The importance of preoperative evaluation using Videostroboscopy 
as a diagnostic tool vastly improves the accuracy of the diagnosis, and 
also acts as an essential tool in assessing the recovery of the patients. 
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Moreover the importance of preoperative voice therapy in 
preparing the patient for much more prolonged post-operative voice 
rehabilitation is also stressed in our study. Adequate voice rest of at least 
2 weeks with strict adherence to post-operative voice therapy is 
absolutely essential to ensure proper healing and improved outcome in 
these patients. 
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PROFORMA 
RADIOFREQUENCY ASSISTED PLASMA ABLATION AND CARBON 
DIOXIDE LASER IN BENIGN LESIONS OF LARYNX – A 
RANDOMIZED PROSPECTIVE DOUBLE BLIND CLINICAL TRIAL 
 
PRE OPERATIVE DETAILS: 
CASE NO.: 
PATIENT ID: 
NAME: 
AGE / SEX: 
ADDRESS: 
 
PRESENTING COMPLAINTS: 
 
PAST HISTORY: 
RISK FACTORS / PRECIPITATING FACTORS: 
GENERAL EXAMINATION: 
 
ENT EXAMINATION: 
 
INDIRECT LARYNGOSCOPY EXAMINATION: 
 
LARYNGEAL ENDOSCOPY: 
VIDEOSTROBOSCOPIC ASSESSMENT: 
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BASIC INVESTIGATIONS: 
Complete hemogram 
Renal function tests 
Random blood sugar 
Chest X ray 
Electrocardiogram 
Urine routine examination 
ANESTHETIC WORK UP / FITNESS: 
PRE OPERATIVE MPT AND VHI SCORES 
PRE OPERATIVE VOICE THERAPY 
 
SURGERY NOTES: 
 
POST OPERATIVE FOLLOW UP: 
 
 AT 2 WEEKS AT 8 WEEKS 
VIDEOSTROBOSCOPY   
M P T   
 
 AT 8 WEEKS 
V H I  
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CONSENT FORM 
 
I Mr. / Mrs. / Miss. ____________________________ aged ____ years, 
S/D/o _______________________ residing at ____________________ 
________________________________________________ is requested 
to be a participant in the study titled “Radiofrequency assisted plasma 
abalation and Carbon dioxide Laser in Benign lesions of larynx – a 
Prospective Randomized double blind trial” conducted by Dr. 
Muralimohan K., a postgraduate trainee in the Department of ENT, 
Coimbatore Medical College Hospital, Coimbatore. I understand that I 
am eligible for the study as per the inclusion criteria, and I also assure 
that I will answer any question and give any clarification about the study 
by agreeing to participate in this study. 
TOPIC OF RESEARCH 
Radiofrequency assisted plasma abalation and Carbon dioxide Laser in 
Benign lesions of larynx – a Prospective Randomized double blind trial 
PURPOSE OF RESEARCH 
• To compare the treatment outcome in Benign lesions of larynx 
using  Radiofrequency assisted plasma ablation and Carbon 
dioxide laser 
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• To find out whether there are significant or potential adverse 
effects of either procedure 
• To determine whether any of these procedures is preferred 
treatment of choice in specific conditions 
PROCEDURES INVOLVED IN THE STUDY 
 Out patients in the ENT OPD, Coimbatore Medical College 
Hospital, who presented with voice complaints were evaluated. Those 
who were diagnosed with benign lesions of the larynx, confirmed by 
videostroboscopy were taken up for surgery – coblation or carbon dioxide 
laser – randomly after preoperative voice therapy. Then the post operative 
follow up is done at 2 weeks and at 8 weeks. The parameters are 
compared. 
DECLINING FROM PARTICIPATION 
 You are hereby made aware that the participation in this study is 
purely voluntary and honorary, and you have all rights to decline from 
participating at any point of time prior to or during the study. 
PRIVACY AND CONFIDENTIALITY 
 You are hereby assured that your privacy is respected and all the 
information will be strictly confidential. 
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AUTHORIZATION TO PUBLISH RESULTS 
 The results may be published for scientific purposes or will be 
presented in scientific groups. In both the cases neither the identity will 
be revealed nor the privacy will be violated. 
 
 
Signature / Left thumb impression of the patient 
Station 
Date 
 
 
 
Signature / Left thumb impression of the witness 
Station 
Date 
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xg;g[jy; gotk;  
 
bgah;  - 
ghypdk; - 
taJ  -  
Kfthp - 
muR nfhit kUj;Jtf;fy;Y}hapy; fhJ \f;F bjhz;il 
kUj;Jt Jiwapy; gl;l nkw;gog;g[ gapYk; khzth; f.Kuspnkhfd; 
mth;fs; nkw;bfhs;Sk; Ma;tpy; bra;Kiw kw;Wk; midj;J 
tptu';fisa[k; nfl;L bfhz;L vdJ re;njf';fis 
bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;.  
,g;gof;F 
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KEY TO MASTER CHART 
CLINICAL HISTORY H HOARSENESS 
 B BREATHY VOICE 
 R ROUGH VOICE 
 D DIPLOPHONIA 
 O OTHERS 
PRECIPITATING / 
RISK FACTORS 
S SMOKER 
 A VOICE ABUSE 
 R LARYNGOPHARYNGEAL 
REFLUX 
 O OTHERS 
   
VHI - VOICE 
HANDICAP INDEX 
11 AND 
ABOVE 
ABNORMAL 
 LESS THAN 
11 
NORMAL 
   
   
MPT - MAXIMUM 
PHONATION TIME 
MALES 25 - 35 SECONDS 
 FEMALES 15 - 25 SECONDS 
   
OUTCOME F FAVOURABLE - TREATED 
AND DISEASE FREE 
 R RECURRENCE 
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1 JAGANNATHAN 54 M H 
S, 
R 
VOCAL CORD NODULE 16 19 * 
  
* 
 
* * 
 
C 15 NIL * 
 
* 
 
* 
 
* 
 
24 * 
 
* 
 
* 
 
* 
 
25 10 F 
2 KANDASAMY 58 M H R VOCAL CORD NODULE 18 21 * 
  
* 
 
* 
 
* L 30 NIL * 
 
* 
 
* 
 
* 
 
26 * 
 
* 
 
* 
 
* 
 
29 10 F 
3 SELVI 47 F B 
 
RECURRENT LARYNGEAL 
PAPILLOMATOSIS 
14 14 
 
* 
 
* 
 
* 
 
* C 30 NIL 
        
15 
        
15 11 F 
4 SUBRAMANI 55 M H S L VOCAL CORD POLYP 12 18 
 
* 
 
* 
   
* L 25 NIL * 
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20 * 
 
* 
 
* 
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22 8 F 
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* 
   
* 
 
* C 15 NIL * 
 
* 
 
* 
 
* 
 
20 * 
 
* 
 
* 
 
* 
 
24 10 F 
7 NAGARAJAN 60 M H 
S, 
R 
VOCAL CORD NODULE 14 18 * 
  
* 
 
* 
 
* L 22 NIL * 
 
* 
 
* 
 
* 
 
21 * 
 
* 
 
* 
 
* 
 
22 8 F 
8 LAKSHMANAN 61 M H S VOCAL CORD NODULE 15 20 * 
  
* 
 
* * 
 
C 12 NIL * 
 
* 
 
* 
 
* 
 
22 * 
 
* 
 
* 
 
* 
 
26 9 F 
9 BHUVANESWARI 26 F B A L VOCAL CORD POLYP 11 14 
 
* 
 
* 
 
* 
 
* L 22 NIL * 
 
* 
 
* 
 
* 
 
17 * 
 
* 
 
* 
 
* 
 
20 6 F 
10 MURUGAN 45 M R 
S, 
A 
REINKE'S EDEMA 16 15 * 
  
* 
 
* * 
 
C 25 NIL 
        
18 
        
19 9 F 
11 KUMARASAMY 33 M R A L VOCAL CORD POLYP 11 22 
 
* 
 
* 
 
* 
 
* L 20 NIL * 
  
* 
 
* 
 
* 23 * 
 
* 
 
* 
 
* 
 
25 7 F 
12 KUPPUSAMY 39 M B 
 
R SULCUS VOCALIS 13 16 
 
* 
 
* 
 
* 
 
* C 20 NIL * 
 
* 
  
* * 
 
18 * 
 
* 
 
* 
 
* 
 
19 10 F 
13 SATHYAMOORTHY 61 M H S R VOCAL CORD POLYP 12 20 
 
* 
 
* 
 
* 
 
* L 25 NIL * 
 
* 
 
* 
 
* 
 
20 * 
 
* 
 
* 
 
* 
 
26 6 F 
14 SIVARAJ 57 M H A L VOCAL CORD POLYP 13 22 * 
  
* 
 
* 
 
* C 15 NIL * 
 
* 
 
* 
 
* 
 
24 * 
 
* 
 
* 
 
* 
 
28 9 F 
15 KRISHNAN 53 M H A R VOCAL CORD POLYP 11 17 
 
* 
 
* 
 
* 
 
* L 30 NIL * 
 
* 
 
* 
 
* 
 
19 * 
 
* 
 
* 
 
* 
 
20 6 F 
16 MASANAM 60 M H A L VOCAL CORD POLYP 14 18 
 
* 
 
* 
 
* 
 
* C 15 NIL * 
 
* 
  
* * 
 
19 * 
 
* 
 
* 
 
* 
 
21 9 F 
17 SUBRAMANIAN 46 M R S L VOCAL CORD POLYP 12 20 
 
* 
 
* 
 
* 
 
* L 18 NIL * 
 
* 
 
* 
 
* 
 
24 * 
 
* 
 
* 
 
* 
 
29 5 F 
 
 
104 
 
18 DHANIKASALAM 44 M R O 
L VOCAL CORD 
GRANULOMA 
13 22 
 
* 
 
* 
 
* 
 
* C 20 NIL * 
  
* 
 
* 
 
* 23 * 
 
* 
 
* 
 
* 
 
24 7 F 
19 MAHARIBA 29 F B A R VOCAL CORD POLYP 11 23 
 
* 
 
* 
 
* 
 
* L 26 NIL * 
 
* 
 
* 
 
* 
 
27 * 
 
* 
 
* 
 
* 
 
31 7 F 
20 NATRAJ 56 M H R VOCAL CORD NODULE 12 26 * 
  
* 
 
* 
 
* C 15 NIL * 
 
* 
 
* 
 
* 
 
28 * 
 
* 
 
* 
 
* 
 
28 7 F 
21 SATHISHKUMAR 31 M R 
 
L VOCAL CORD POLYP 14 19 
 
* 
 
* 
 
* 
 
* L 30 NIL * 
 
* 
 
* 
 
* 
 
21 * 
 
* 
 
* 
 
* 
 
23 10 F 
22 MUTHURAJ 41 M R 
 
R VOCAL CORD CYST 12 17 
 
* 
 
* 
 
* 
 
* C 18 NIL * 
 
* 
 
* 
 
* 
 
18 * 
 
* 
 
* 
 
* 
 
19 9 F 
23 PARAMESHWARI 45 F D 
 
L VOCAL CORD CYST 12 16 
 
* 
 
* 
 
* 
 
* L 30 NIL * 
 
* 
  
* * 
 
18 * 
 
* 
 
* 
 
* 
 
21 8 F 
24 AROON 62 M H R VOCAL CORD NODULE 11 21 * 
  
* 
 
* * 
 
C 10 NIL * 
  
* 
 
* 
 
* 26 * 
 
* 
 
* 
 
* 
 
27 7 F 
25 RAMACHANDRAN 52 M H S,A L VOCAL CORD POLYP 14 20 * 
  
* 
 
* 
 
* L 20 NIL * 
 
* 
 
* 
 
* 
 
22 * 
 
* 
 
* 
 
* 
 
23 8 F 
26 UMAMAHESWARI 35 F R 
 
RECURRENT LARYNGEAL 
PAPILLOMATOSIS 
15 13 
 
* 
 
* 
 
* 
 
* C 25 NIL 
        
14 
        
14 13 R 
27 RAMATHAL 61 F H S,A REINKE'S EDEMA 16 12 * 
  
* 
 
* * 
 
C 20 NIL 
        
19 
        
20 9 F 
28 KARUPPASAMY 35 M R 
 
R VOCAL CORD POLYP 12 19 
 
* 
 
* 
 
* 
 
* L 20 NIL * 
 
* 
 
* 
 
* 
 
21 * 
 
* 
 
* 
 
* 
 
26 7 F 
29 VAJRAVEL 65 M H 
 
VOCAL CORD NODULE 11 20 * 
  
* 
 
* 
 
* L 20 NIL * 
 
* 
 
* 
 
* 
 
21 * 
 
* 
 
* 
 
* 
 
23 5 F 
30 UMAMAHESWARI 27 F B A L VOCAL CORD POLYP 11 16 
 
* 
 
* 
 
* 
 
* C 15 NIL * 
 
* 
 
* 
 
* 
 
19 * 
 
* 
 
* 
 
* 
 
24 5 F 
 
 
